Publicacions en col·laboració amb investigadors/es de Brigham and Women's Hospital (15)

2024

  1. Addressing residual risk beyond statin therapy: New targets in the management of dyslipidaemias–A report from the European Society of Cardiology Cardiovascular Round Table

    Journal of Clinical Lipidology

  2. Comparative Gene Signature of Nociceptors Innervating Mouse Molar Teeth, Cranial Meninges, and Cornea

    Anesthesia and Analgesia, Vol. 139, Núm. 1, pp. 226-234

2021

  1. Advanced cancer is also a heart failure syndrome: a hypothesis

    Journal of Cachexia, Sarcopenia and Muscle, Vol. 12, Núm. 3, pp. 533-537

  2. Advanced cancer is also a heart failure syndrome: a hypothesis

    European Journal of Heart Failure, Vol. 23, Núm. 1, pp. 140-144

2019

  1. Ticagrelor in patients with diabetes and stable coronary artery disease with a history of previous percutaneous coronary intervention (THEMIS-PCI): a phase 3, placebo-controlled, randomised trial

    The Lancet, Vol. 394, Núm. 10204, pp. 1169-1180

2018

  1. Cardiac troponin T concentrations, reversible myocardial ischemia, and indices of left ventricular remodeling in patients with suspected stable angina pectoris: A DOPPLER-CIP substudy

    Clinical Chemistry, Vol. 64, Núm. 9, pp. 1371-1379

  2. Clinical Trial Principles and Endpoint Definitions for Paravalvular Leaks in Surgical Prosthesis

    European Heart Journal, Vol. 39, Núm. 15, pp. 1224-1245

2017

  1. Cardiovascular efficacy and safety of bococizumab in high-risk patients

    New England Journal of Medicine, Vol. 376, Núm. 16, pp. 1527-1539

  2. Clinical Trial Principles and Endpoint Definitions for Paravalvular Leaks in Surgical Prosthesis: An Expert Statement

    Journal of the American College of Cardiology, Vol. 69, Núm. 16, pp. 2067-2087

  3. Evolocumab and clinical outcomes in patients with cardiovascular disease

    New England Journal of Medicine, Vol. 376, Núm. 18, pp. 1713-1722

  4. Lipid-lowering efficacy and safety of alirocumab in patients with or without diabetes: A sub-analysis of ODYSSEY COMBO II

    Diabetes, Obesity and Metabolism, Vol. 19, Núm. 7, pp. 989-996

2016

  1. Edoxaban Versus Warfarin in Atrial Fibrillation Patients at Risk of Falling: ENGAGE AF–TIMI 48 Analysis

    Journal of the American College of Cardiology, Vol. 68, Núm. 11, pp. 1169-1178

2014

  1. Imaging to select and guide transcatheter aortic valve implantation

    European Heart Journal, Vol. 35, Núm. 24, pp. 1578-1587

2013

  1. Edoxaban versus warfarin in patients with atrial fibrillation

    New England Journal of Medicine, Vol. 369, Núm. 22, pp. 2093-2104

2009

  1. Effect of clopidogrel added to aspirin in patients with atrial fibrillation

    New England Journal of Medicine, Vol. 360, Núm. 20, pp. 2066-2078